- Home
- LQDA vs GSHD Comparison
LQDA vs GSHD Comparison
Compare LQDA & GSHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- GSHD
- Stock Information
- Founded
- LQDA 2004
- GSHD 2003
- Country
- LQDA United States
- GSHD United States
- Employees
- LQDA N/A
- GSHD N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- GSHD Specialty Insurers
- Sector
- LQDA Health Care
- GSHD Finance
- Exchange
- LQDA Nasdaq
- GSHD Nasdaq
- Market Cap
- LQDA 1.9B
- GSHD 2.2B
- IPO Year
- LQDA 2018
- GSHD 2018
- Fundamental
- Price
- LQDA $24.53
- GSHD $68.09
- Analyst Decision
- LQDA Strong Buy
- GSHD Hold
- Analyst Count
- LQDA 9
- GSHD 10
- Target Price
- LQDA $32.67
- GSHD $101.50
- AVG Volume (30 Days)
- LQDA 2.2M
- GSHD 404.2K
- Earning Date
- LQDA 11-03-2025
- GSHD 10-22-2025
- Dividend Yield
- LQDA N/A
- GSHD 8.70%
- EPS Growth
- LQDA N/A
- GSHD 68.12
- EPS
- LQDA N/A
- GSHD 1.14
- Revenue
- LQDA $19,322,000.00
- GSHD $353,231,000.00
- Revenue This Year
- LQDA $424.31
- GSHD $16.87
- Revenue Next Year
- LQDA $359.32
- GSHD $22.03
- P/E Ratio
- LQDA N/A
- GSHD $59.82
- Revenue Growth
- LQDA 30.20
- GSHD 25.01
- 52 Week Low
- LQDA $9.71
- GSHD $64.41
- 52 Week High
- LQDA $29.94
- GSHD $130.39
- Technical
- Relative Strength Index (RSI)
- LQDA 52.65
- GSHD 41.04
- Support Level
- LQDA $22.05
- GSHD $67.47
- Resistance Level
- LQDA $24.34
- GSHD $75.00
- Average True Range (ATR)
- LQDA 1.26
- GSHD 3.41
- MACD
- LQDA 0.10
- GSHD 0.52
- Stochastic Oscillator
- LQDA 60.51
- GSHD 25.90
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.